High Frequency Strand Slippage Mutations in CTCF in MSI-Positive Endometrial Cancers

Human Mutation

Volumn 35, Issue 1, 2014, Pages 63-65

  Zighelboim, Israel ^a,e   Mutch, David G ^a   Knapp, Amy ^b   Ding, Li ^a,c,d   Xie, Mingchao ^a,c,d   Cohn, David E ^b   Goodfellow, Paul J ^b  

^a USA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CTCF; Endometrial cancer; MSI; Strand slippage mutation; Tumor suppressor

Indexed keywords

TRANSCRIPTION FACTOR CTCF;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; EARLY CANCER; ENDOMETRIUM CANCER; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INDEL MUTATION; MISMATCH REPAIR; NONSENSE MEDIATED MRNA DECAY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; DNA MISMATCH REPAIR; ENDOMETRIAL NEOPLASMS; EXOME; FEMALE; FRAMESHIFT MUTATION; GENETIC VARIATION; HAPLOINSUFFICIENCY; HUMANS; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MUTATION RATE; NONSENSE MEDIATED MRNA DECAY; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 84890797818     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22463     Document Type: Article

References (21)

1. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. Pten is essential for embryonic development and tumour suppression. Nature Genetics 1998;19(August):348-355.
2. Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D. Microsatellite instability in sporadic endometrial carcinoma. Journal of the National Cancer Institute 1994;86:1216-1221.
3. Goodfellow PJ, Buttin BM, Herzog TJ, Rader JS, Gibb RK, Swisher E, Look K, Walls KC, Fan MY, Mutch DG. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A, 2003;100:5908-5913
4. Gregor A, Oti M, Kouwenhoven EN, Hoyer J, Sticht H, Ekici AB, Kjaergaard S, Rauch A, Stunnenberg HG, Uebe S, Vasileiou G, Reis A, et al. De novo mutations in the genome organizer CTCF cause intellectual disability. Am J Hum Genet 2013;93:124-131.
5. Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, Whelan AJ, Williams G, Bracamontes D, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science, 2009;325:965. doi: 10.1126/science.1174334.
6. Hoyer J, Ekici AB, Endele S, Popp B, Zweier C, Wiesener A, Wohlleber E, Dufke A, Rossier E, Petsch C, Zweier M, Göhring I, et al. Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability. Am J Hum Genet 2012;90:565-572.
7. Joshi A, Wang H, Jiang G, Douglas W, Chan JS, Korach KS, Ellenson LH. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor alpha. Am J Pathol 2012;180:2536-2547.
8. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013;497:67-73.
9. Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J, Kirsch DG, Golub TR, Jacks T. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 2009;23:2700-2704.
10. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, et al. Inactivation of the type II TGF-b receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-1338.
11. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu CG, et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009;41:365-370.
12. Merkenschlager M, Odom DT. CTCF and cohesin: linking gene regulatory elements with their targets. Cell 2013;152:1285-1297.
13. Schwartz S Jr, Yamamoto H, Navarro M, Maestro M, Reventós J, Perucho M. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999;59:2995-3002.
14. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
15. Swisher EM, Mutch DG, Herzog TJ, Rader JS, Kowalski LD, Elbendary A, Goodfellow PJ. Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair. J Soc Gynecol Investig 1998;5:210-216.
16. Tsurusaki Y, Okamoto N, Ohashi H, Kosho T, Imai Y, Hibi-Ko Y, Kaname T, Naritomi K, Kawame H, Wakui K, Fukushima Y, Homma T, et al. Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat Genet 2012;44:376-378.
17. van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu Rev Genet 2011;45:81-104.
18. Vassileva V, Millar A, Briollais L, Chapman W, Bapat B. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. Cancer Research 2002;62:4095-4099.
19. Witcher M, Emerson BM. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell 2009;34:271-284.
20. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 2009;25:2865-2871
21. Zighelboim I, Schmidt AP, Gao F, Thaker PH, Powell MA, Rader JS, Gibb RK, Mutch DG, Goodfellow PJ. ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes. J Clin Oncol 2009;27:3091-3096.